Cart
sales@molnova.com
Home -
Products -
Others -
Other Targets -
(1E)-3-methoxy-8,12-epoxygermacra-1,7,10,11-tetraen-6-one
(1E)-3-methoxy-8,12-epoxygermacra-1,7,10,11-tetraen-6-one
CAS No. 1393342-06-7
(1E)-3-methoxy-8,12-epoxygermacra-1,7,10,11-tetraen-6-one( —— )
Catalog No. M31993 CAS No. 1393342-06-7
(1E)-3-methoxy-8,12-epoxygermacra-1,7,10,11-tetraen-6-one is a natural product for research related to life sciences.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 603 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(1E)-3-methoxy-8,12-epoxygermacra-1,7,10,11-tetraen-6-one
-
NoteResearch use only, not for human use.
-
Brief Description(1E)-3-methoxy-8,12-epoxygermacra-1,7,10,11-tetraen-6-one is a natural product for research related to life sciences.
-
Description(1E)-3-methoxy-8,12-epoxygermacra-1,7,10,11-tetraen-6-one is a natural product for research related to life sciences.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1393342-06-7
-
Formula Weight260.3
-
Molecular FormulaC16H20O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Nitisinone
Nitisinone(SC0735) is an inhibitor of the enzyme 4-hydroxyphenylpyruvate dioxygenase.
-
Pressinoic Acid
Pressinoic Acid is a peptide with potent corticotrophin-releasing activity. It is also an oxytocin inhibitor; it induces maternal behavior.
-
Nemvaleukin alfa
Nemvaleukin alfa (ALKS 4230) is an interleukin 2 fusion protein, a selective agonist of the medium-affinity IL-2 receptor, produced by fusion of the IL-2Ralpha subunit of the circularly arranged interleukin-2 (IL-2) and IL-2 receptor (IL-2R) complexes, which drives antitumor Immunity and inhibits tumor growth in small cell lung cancer.
